Adam Davidson, CEO of Trident Royalties, discusses offtake milestones and catalysts to boost FY24. Watch the video here.
Lets hope the BOD use this 10 day period wisely to "manage out" any other highly "forseeable" delays to critical path activities............ presumably materials are on site, inspected, signed off and ready to go and imminent future deliveiries are being secured and not "subject to" covid related delays (eg the delivery driver has to self isolate) ............ key spare parts have been delivered........ O&M manuals have been inspected and approved (ie verified as containing the required level of detail and information) and RMS operational staff have been / will be fully briefed on their contents (via zoom if necessary) etc etc
One would like to think that a pro-active BOD would have incorporated contingency plans or "back up" options in the event of 2 nominated commissioning engineers testing positive test for Covid (whilst travelling internationally)......... I mean its not exactly in the "unforeseen" incident category. How about flying out 2 more engineers with immediate effect (to do no more than what presumably is to fulfil a contractual obligation)? and as "belt and braces" an additional 2 more enineers to that in case the first 2 need to isolate. Is there no-one based or currently in the UK who can complete this task? All highly foreseeable............ lets see how good this BOD really is on the "management" front. ........ or perhaps a complete change is required. Incompetency should not be rewarded with more share issues / warrent options.
The RNS issued today is what can only be described as “extremely positive” on many fronts.
On the coronavirus testing, some contributors are clearly blinded by a misconstrued expectation that everything, regarding Testing, is happening “now!” and the “window of opportunity is small” and that Avacta has, to some degree, missed the boat. I believe nothing could be further from the truth. Putting aside the inevitable Vaccine news that will be reported in the coming months including Vaccine rollout commencing in earnest in 2021, coronavirus testing (and the associated use of “freedom passports”) will be a feature of all our lives for many years to come and will be the effective and significant managed route back to some kind of prevailing and stable “normality”. IMO Avacta is “on track” to produce the stand out “World class” User friendly test. Over the coming years (and 2021 in particular) the market for “testing” will dwarf that for “Vaccines”. Daily / weekly testing will become a regular feature of all of our lives. Indeed people, on a personal level, may review the need for being injected with an “unproven Vaccine” once the effectiveness and benefits of testing become transparent and are better appreciated. A Vaccine may at best be seen as “belt and braces”, but once taken will not remove or reduce the need for regular and continuous testing. The two will continue to work in parallel and will complement each other (i.e. it’s not a case of “Vaccine v Testing……… who wins?”)….. although the MMs would like you to think that is the case.
The writing has been on the wall by way of the frequent positive “LFT comments” from Boris and MH in recent months as they were clearly aware of what was “on the horizon”. It is now clearly coming to fruition. The RNS today also confirms that Avacta is on track and extremely well placed to exploit the very significant opportunities, on many fronts, in the not too distant future. gla
The RNS issued today is what can only be described as “extremely positive” on many fronts.
On the coronavirus testing, some contributors are clearly blinded by a misconstrued expectation that everything, regarding Testing, is happening “now!” and the “window of opportunity is small” and that Avacta has, to some degree, missed the boat. I believe nothing could be further from the truth. Putting aside the inevitable Vaccine news that will be reported in the coming months including Vaccine rollout commencing in earnest in 2021, coronavirus testing (and the associated use of “freedom passports”) will be a feature of all our lives for many years to come and will be the effective and significant managed route back to some kind of prevailing and stable “normality”. IMO Avacta is “on track” to produce the stand out “World class” User friendly test. Over the coming years (and 2021 in particular) the market for “testing” will dwarf that for “Vaccines”. Daily / weekly testing will become a regular feature of all of our lives. Indeed people, on a personal level, may review the need for being injected with an “unproven Vaccine” once the effectiveness and benefits of testing become transparent and are better appreciated. A Vaccine may at best be seen as “belt and braces”, but once taken will not remove or reduce the need for regular and continuous testing. The two will continue to work in parallel and will complement each other (i.e. it’s not a case of “Vaccine v Testing……… who wins?”)….. although the MMs would like you to think that is the case.
The writing has been on the wall by way of the frequent positive “LFT comments” from Boris and MH in recent months as they were clearly aware of what was “on the horizon”. It is now clearly coming to fruition. The RNS today also confirms that Avacta is on track and extremely well placed to exploit the very significant opportunities, on many fronts, in the not too distant future. gla
The RNS issued today is what can only be described as “extremely positive” on many fronts.
On the coronavirus testing, some contributors are clearly blinded by a misconstrued expectation that everything, regarding Testing, is happening “now!” and the “window of opportunity is small” and that Avacta has, to some degree, missed the boat. I believe nothing could be further from the truth. Putting aside the inevitable Vaccine news that will be reported in the coming months including Vaccine rollout commencing in earnest in 2021, coronavirus testing (and the associated use of “freedom passports”) will be a feature of all our lives for many years to come and will be the effective and significant managed route back to some kind of prevailing and stable “normality”. IMO Avacta is “on track” to produce the stand out “World class” User friendly test. Over the coming years (and 2021 in particular) the market for “testing” will dwarf that for “Vaccines”. Daily / weekly testing will become a regular feature of all of our lives. Indeed people, on a personal level, may review the need for being injected with an “unproven Vaccine” once the effectiveness and benefits of testing become transparent and are better appreciated. A Vaccine may at best be seen as “belt and braces”, but once taken will not remove or reduce the need for regular and continuous testing. The two will continue to work in parallel and will complement each other (i.e. it’s not a case of “Vaccine v Testing……… who wins?”)….. although the MMs would like you to think that is the case.
The writing has been on the wall by way of the frequent positive “LFT comments” from Boris and MH in recent months as they were clearly aware of what was “on the horizon”. It is now clearly coming to fruition. The RNS today also confirms that Avacta is on track and extremely well placed to exploit the very significant opportunities, on many fronts, in the not too distant future. gla
I would assume Avacta are developing an App (with partners) as part of the "full package" solution.......... the app will uniquely indentify a User by using unique identifiers / biometrics / photo ID etc just like a "real passport" .......... and would account for some of the "perceived delays"
Well that little spate of selling appears to be over.............. onwards and upwards......... slowly as she goes :)
Predictable minor fall backs as some investors inevitably sell (some) on percieved local "spikes"...... and why not? its their money, do whats right for you ........ but Im staying far away from the sell button for the forseeable :) gla
The genie is finally out of the bottle......... to a small but wider audience ........... official announcements, in the public domain, in the "very near future"............ sit back and enjoy from here on in :)
The initial early fall back from yesterday's gain was predictable (in line with the strategy and psychological "daily plays" of the MMs........ thereafter the re-build back to 130 was encouraging and re-affirmed that "on the balance of probability" there was significant substance to yesterday's gains)........ the "jump" from 131 to 138 at one click at 11.10am was extremely encouraging and potentially very significant........... albeit you always need to be mindful that the MMs will be "raising their game" to a new level over the "daily plays" on this share. This could now be the start of an "exceedingly good" period :) (will avoid an obvious Ramp). Stay Alert! and gla